biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0b1-01a-12w-a071-09
biospecimen_aliquot__bcr_aliquot_uuid	de20290a-1560-41fd-896b-a3ae1103423e
biospecimen_aliquot__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099029257
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.50
biospecimen_aliquot__date_of_shipment	2010-09-08
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a071
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	40.00
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	80.00
biospecimen_analyte__analyte_type	repli-g (qiagen) dna
biospecimen_analyte__analyte_type_id	w
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0b1-01a-12w
biospecimen_analyte__bcr_analyte_uuid	749f68a9-d139-440a-a2aa-8a4c9ddc3849
biospecimen_analyte__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__subportion_sequence	2
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0b1
biospecimen_diagnostic_slides__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	cc60d284-04fb-4b73-90aa-fce9185dadb6
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0b1
biospecimen_normal_control__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_portion__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0b1-01a-12
biospecimen_portion__bcr_portion_uuid	45fd049f-6859-4c65-9eaa-ad4488693323
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	12
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0b1-01a-12w
biospecimen_protocol__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_protocol__experimental_protocol_type	repli-g
biospecimen_sample__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_sample__bcr_sample_uuid	31532d08-cb6e-40fa-9dfe-d2c6d037dcb1
biospecimen_sample__days_to_collection	1071
biospecimen_sample__initial_weight	740
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0b1.baeb6705-fcdc-4b40-b1cb-d926b8287f92.pdf
biospecimen_sample__pathology_report_uuid	baeb6705-fcdc-4b40-b1cb-d926b8287f92
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_shipment_portion__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	cb0ffa62-bbfe-481a-9eda-099f9381319e
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13c
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-bh-a0b1-01a-21-a13c-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0b1-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0b1-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	2739b8f3-4b3b-4f93-8a37-decb4367178a
biospecimen_slide__image_file_name	tcga-bh-a0b1-01a-01-tsa.2739b8f3-4b3b-4f93-8a37-decb4367178a.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	72
biospecimen_slide__percent_stromal_cells	2
biospecimen_slide__percent_tumor_cells	25
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0b1
biospecimen_tumor_sample__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
clinical_drug__bcr_drug_barcode	tcga-bh-a0b1-d15430
clinical_drug__bcr_drug_uuid	1b65710d-8e59-4084-9524-988dec29a8b3
clinical_drug__bcr_patient_barcode	tcga-bh-a0b1
clinical_drug__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
clinical_drug__form_completion_date	2010-11-3
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	232
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	53
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0b1-f15429
clinical_follow_up__bcr_followup_uuid	555cc286-5677-4a66-8fd4-e7b131d2e99b
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0b1
clinical_follow_up__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2010-11-3
clinical_follow_up__last_contact_days_to	1148
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_nte__bcr_patient_barcode	tcga-bh-a0b1
clinical_nte__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
clinical_patient__age_at_diagnosis	66
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant|right
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-bh-a0b1
clinical_patient__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
clinical_patient__birth_days_to	-24315
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__form_completion_date	2010-11-3
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	1148
clinical_patient__lymph_nodes_examined_count	15
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0b1
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	40-49%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0b1
clinical_radiation__bcr_patient_uuid	b4e4fea2-b802-4a86-923e-3fcbd3c708fe
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0b1-r15434
clinical_radiation__bcr_radiation_uuid	6cbdf1e7-e2bb-4eec-9c61-547430a54e0a
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-11-3
clinical_radiation__radiation_adjuvant_fractions_total	28
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	343
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	287
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0B1-01A-12W-A071-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0B1-01A-12W-A071-09.bed.meta
manually_curated__id	tcga-bh-a0b1-01a-12w-a071-09
manually_curated__md5sum	4a9787b76eeee818130d10353c7fd0f2
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	de20290a-1560-41fd-896b-a3ae1103423e
manually_curated__tumor_tag	brca
